About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of Bimatoprost 0.01% in the Clinical Setting

A Study of Bimatoprost 0.01% in the Clinical Setting

NCT01814761·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

Age

20–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of primary open-angle glaucoma or ocular hypertension
Determined by the treating physician to require treatment with bimatoprost 0.01%.

You may not be if

Previous use of Lumigan® 0.01%

The record

StatusCompleted

PhaseNo phase

Taking part312

StartedMay 2013

UpdatedOct 26, 2015

Conditions

Glaucoma, Primary Open Angle Ocular Hypertension

Where1

Taichung, Taiwan